GB0701171D0 - Compositions and uses thereof - Google Patents

Compositions and uses thereof

Info

Publication number
GB0701171D0
GB0701171D0 GBGB0701171.1A GB0701171A GB0701171D0 GB 0701171 D0 GB0701171 D0 GB 0701171D0 GB 0701171 A GB0701171 A GB 0701171A GB 0701171 D0 GB0701171 D0 GB 0701171D0
Authority
GB
United Kingdom
Prior art keywords
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0701171.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Innovations Ltd filed Critical Imperial Innovations Ltd
Priority to GBGB0701171.1A priority Critical patent/GB0701171D0/en
Publication of GB0701171D0 publication Critical patent/GB0701171D0/en
Priority to PCT/GB2008/000217 priority patent/WO2008090331A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0701171.1A 2007-01-22 2007-01-22 Compositions and uses thereof Ceased GB0701171D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0701171.1A GB0701171D0 (en) 2007-01-22 2007-01-22 Compositions and uses thereof
PCT/GB2008/000217 WO2008090331A1 (en) 2007-01-22 2008-01-22 Serotonin reuptake inhibitors for treating arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0701171.1A GB0701171D0 (en) 2007-01-22 2007-01-22 Compositions and uses thereof

Publications (1)

Publication Number Publication Date
GB0701171D0 true GB0701171D0 (en) 2007-02-28

Family

ID=37846742

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0701171.1A Ceased GB0701171D0 (en) 2007-01-22 2007-01-22 Compositions and uses thereof

Country Status (2)

Country Link
GB (1) GB0701171D0 (en)
WO (1) WO2008090331A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715428D0 (en) * 2007-08-08 2007-09-19 Imp Innovations Ltd Compositions and uses thereof
BRPI0918722A2 (en) 2008-09-11 2015-12-01 Astellas Pharma Inc pharmaceutical composition to treat nociceptive pain
RU2703723C1 (en) * 2018-08-06 2019-10-22 Федеральное Государственное бюджетное образовательное учреждение высшего образования Дагестанский государственный медицинский университет Министерства здравоохранения Российской Федерации Даггосмедуниверситет Method of correction of anxiety-depressive disorders in patients with systemic connective tissue diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1553955A4 (en) * 2002-09-24 2008-11-05 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
WO2005000786A1 (en) * 2003-05-23 2005-01-06 Transform Pharmaceuticals, Inc. Sertraline compositions
WO2005000811A1 (en) * 2003-06-11 2005-01-06 Eli Lilly And Company 3-aminopyrrolidines as inhibitors of monoamine uptake
US20050192261A1 (en) * 2003-09-15 2005-09-01 Jost-Price Edward R. Methods and reagents for the treatment of immunoinflammatory disorders
EP1899303B1 (en) * 2005-06-28 2010-09-15 NeuroSearch A/S Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Also Published As

Publication number Publication date
WO2008090331A1 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
ZA201001300B (en) Antigen-asjuvant compositions and methods
EP2219554A4 (en) Progesterone-containing compositions and devices
EP2162004A4 (en) Antimicrobial compositions and uses thereof
DK2139466T3 (en) Magnesium Compositions and Uses Thereof
ZA201003696B (en) Compositions and devices
ZA201008887B (en) Oral compositions and uses thereof
ZA201007920B (en) Oral compositions and uses thereof
HK1144772A1 (en) Protopanaxadiol-type ginsenoside compositions and uses thereof
EP2101731A4 (en) Endoxifen methods and compositions
GB0721291D0 (en) Methods and compositions
IL211204A0 (en) Mucoadherents compositions and their use
GB0706077D0 (en) Methods, Compositions and uses thereof
TWI367763B (en) Compositions and devices
GB0622399D0 (en) Novel compositions and uses thereof
GB0717376D0 (en) Composition and manufacture thereof
EP2088865A4 (en) Guggulphospholipid methods and compositions
GB0617171D0 (en) Novel compositions and methods
GB0809912D0 (en) Novel compositions and uses thereof
GB0719526D0 (en) Compositions and methods
GB0702871D0 (en) Improved compositions and combinations 1
EP1998753A4 (en) High-deposition compositions and uses thereof
GB0615609D0 (en) Uses and compositions comprising miRNAs
EP2247303A4 (en) Haemostasis- modulating compositions and uses therefor
GB0715428D0 (en) Compositions and uses thereof
GB0701170D0 (en) Compositions and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)